New low-dose estrogen approved for prevention of postmenopausal osteoporosis.
D000368:Aged; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP); C466383:Prempro; D017258:Medroxyprogesterone Acetate